Learn more about the complex process of developing cell-based therapies for cancer, including the rigorous laboratory assessments and regulatory approvals required. This article also highlights the role of advanced analytics, technology solutions and clinical research services in this process.
Leverage a global network of Phase I clinical pharmacology units to build diversity in patient populations and access a range of geographic regions for early clinical development (ECD) programs.
Predict enrollment more accurately and increase the number of patients per site using data-driven patient recruitment solutions.
Build on our experience of more than 245 rare disease studies in 96 countries to fulfill your promise of hope to millions around the world.
.svg){kind=icon}
